Cardiovascular risk assessment in children following kidney transplantation
© 2012 John Wiley & Sons A/S..
CV diseases are the leading cause of death among patients with ESRD. RTX decreases the CV risk; however, it still remains definitely higher than that of the general population. Large multicenter and longitudinal studies are difficult to perform and hard end-points of CV events are usually missing among pediatric population. Thus, appropriate estimation of CV risk is of crucial importance to define the potential hazards and to evaluate the effect of treatments aimed to reduce the risk. A number of validated non-invasive methods are available to assess the extent of CV damage in adults, such as calcification scores, cIMT, aPWV, 24-h ABPM, AASI, and HRV; however, they need adaptation, standardization, and validation in pediatric studies. cIMT and PWV are the most promising methods, as pediatric normative values are already present. The up-to-date treatment of ESRD aims not only to save life, but to offer the patient a life expectancy approaching that of the healthy population and to ensure a reasonable quality of life.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Pediatric transplantation - 16(2012), 6 vom: 02. Sept., Seite 564-76 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dégi, Arianna [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 10.01.2013 Date Revised 06.08.2012 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/j.1399-3046.2012.01730.x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM218590709 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM218590709 | ||
| 003 | DE-627 | ||
| 005 | 20231224040822.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/j.1399-3046.2012.01730.x |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0728.xml |
| 035 | |a (DE-627)NLM218590709 | ||
| 035 | |a (NLM)22694162 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dégi, Arianna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cardiovascular risk assessment in children following kidney transplantation |
| 264 | 1 | |c 2012 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.01.2013 | ||
| 500 | |a Date Revised 06.08.2012 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2012 John Wiley & Sons A/S. | ||
| 520 | |a CV diseases are the leading cause of death among patients with ESRD. RTX decreases the CV risk; however, it still remains definitely higher than that of the general population. Large multicenter and longitudinal studies are difficult to perform and hard end-points of CV events are usually missing among pediatric population. Thus, appropriate estimation of CV risk is of crucial importance to define the potential hazards and to evaluate the effect of treatments aimed to reduce the risk. A number of validated non-invasive methods are available to assess the extent of CV damage in adults, such as calcification scores, cIMT, aPWV, 24-h ABPM, AASI, and HRV; however, they need adaptation, standardization, and validation in pediatric studies. cIMT and PWV are the most promising methods, as pediatric normative values are already present. The up-to-date treatment of ESRD aims not only to save life, but to offer the patient a life expectancy approaching that of the healthy population and to ensure a reasonable quality of life | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Kerti, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Kis, Eva |e verfasserin |4 aut | |
| 700 | 1 | |a Cseprekál, Orsolya |e verfasserin |4 aut | |
| 700 | 1 | |a Tory, Kálmán |e verfasserin |4 aut | |
| 700 | 1 | |a Szabó, Attila J |e verfasserin |4 aut | |
| 700 | 1 | |a Reusz, George S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric transplantation |d 1997 |g 16(2012), 6 vom: 02. Sept., Seite 564-76 |w (DE-627)NLM097406473 |x 1399-3046 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2012 |g number:6 |g day:02 |g month:09 |g pages:564-76 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/j.1399-3046.2012.01730.x |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2012 |e 6 |b 02 |c 09 |h 564-76 | ||